CLR325

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLR325, covering 2020-03-04 to 2020-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CLR325 in Chronic Stable Heart Failure Patients. [Phase 2]